Fortress Biotech Sees Upgrades Amid Investor Shifts
"Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."
- Latest
- Trending
"Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."
Bitcoin Whales Sell $1.2B in 2 Weeks, Impacting Market with Increased Sell-Side Liquidity as Old Investors Take Unprecedented Profits.
Lionsgate and Media Capital Technologies sign a multi-year deal for diverse film financing, ensuring a slate of exciting, big-budget movies.
Discover why Best Buy, GameStop, and Micron Technology are stocks to watch this week with upgrades, shareholder buzz, and strong ...
Bitcoin dips below $66K. Michael Saylor of MicroStrategy advises focus on crypto fundamentals, advocates buying the dip amid market volatility.
CrediBULL Crypto predicts Ethereum to hit $10,000, despite recent declines. Key levels: $3,399 support, $3,668 initial resistance. Eyes on ETH's ...
Advent and ADIA invest $2.5-$3B, valuing Fisher Investments at $12.75B. Founder Ken Fisher sells holdings. New board member: Advent's Mussafer.
Nexalin Technology: 0.7% institutional, 7% insider ownership. Beta of 5.13 reveals high volatility; rivals surpass in 8 of 10 factors. ...
Weibo's beta of 0.24 shows lower volatility compared to Trump Media's beta of 6.14. Weibo, founded in 2009, has 3% ...
NaaS Technology (NASDAQ:NAAS) posted Q1 losses with EPS at ($1.40). Laidlaw Wealth Management boosted stakes 242.8% in Q4.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.